Literature DB >> 25881994

Barrier function in the ocular surface: from conventional paradigms to new opportunities.

Yuan-Yuh Leong1, Louis Tong2.   

Abstract

By providing a physical and immunological barrier, the ocular surface serves the important function of protecting the vision apparatus. The barrier function keeps the cornea relatively dehydrated, preserving transparency for transmission of light. In many instances, dysfunction of this barrier leads to clinical diseases, such as dry eye, infectious keratitis, allergic keratoconjunctivitis, chemical injury, and persistent epithelial defects. Herein, we review the components of the epithelial barrier in the ocular surface, i.e., the transcellular and paracellular pathways, and describe the methodologies for measuring barrier function in vitro, in animals, and in clinical studies. The usefulness and limitations of these techniques are discussed. Recent studies in the regulation of individual tight junction proteins, the occludins, the zonula occludens, and the claudins, are also reviewed. Several potential interventional strategies based on the knowledge gained from these studies are noted.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  barrier function; cornea; dry eye; epithelium; inflammation; signaling; tight junctions

Mesh:

Year:  2015        PMID: 25881994     DOI: 10.1016/j.jtos.2014.10.003

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  16 in total

Review 1.  Immunologic mechanism of fungal keratitis.

Authors:  Rui-Bo Yang; Li-Ping Wu; Xiao-Xiao Lu; Chen Zhang; Hui Liu; Yue Huang; Zhe Jia; Yi-Chen Gao; Shao-Zhen Zhao
Journal:  Int J Ophthalmol       Date:  2021-07-18       Impact factor: 1.779

Review 2.  The ocular surface immune system through the eyes of aging.

Authors:  Jeremias G Galletti; Cintia S de Paiva
Journal:  Ocul Surf       Date:  2021-02-20       Impact factor: 5.033

Review 3.  The molecular mechanisms of action of PPAR-γ agonists in the treatment of corneal alkali burns (Review).

Authors:  Hongyan Zhou; Wensong Zhang; Miaomiao Bi; Jie Wu
Journal:  Int J Mol Med       Date:  2016-08-04       Impact factor: 4.101

Review 4.  Relevance of Lipid-Based Products in the Management of Dry Eye Disease.

Authors:  Jean-Sébastien Garrigue; Mourad Amrane; Marie-Odile Faure; Juha M Holopainen; Louis Tong
Journal:  J Ocul Pharmacol Ther       Date:  2017-09-28       Impact factor: 2.671

5.  Epithelial changes with corneal punctate epitheliopathy in type 2 diabetes mellitus and their correlation with time to healing.

Authors:  Jing-Hao Qu; Li Li; Lei Tian; Xiao-Yu Zhang; Ravi Thomas; Xu-Guang Sun
Journal:  BMC Ophthalmol       Date:  2018-01-04       Impact factor: 2.209

6.  Effects of histatin-1 peptide on human corneal epithelial cells.

Authors:  Dhara Shah; Marwan Ali; Deepak Shukla; Sandeep Jain; Vinay Kumar Aakalu
Journal:  PLoS One       Date:  2017-05-23       Impact factor: 3.240

7.  Tissue resident memory T cells in the human conjunctiva and immune signatures in human dry eye disease.

Authors:  Tanima Bose; Ryan Lee; Aihua Hou; Louis Tong; K George Chandy
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

Review 8.  Diabetic corneal neuropathy: clinical perspectives.

Authors:  Guzel Bikbova; Toshiyuki Oshitari; Takayuki Baba; Mukharram Bikbov; Shuichi Yamamoto
Journal:  Clin Ophthalmol       Date:  2018-05-25

9.  Corneal epithelial permeability to fluorescein in humans by a multi-drop method.

Authors:  Sangly P Srinivas; Arushi Goyal; Deepti P Talele; Sanjay Mahadik; Rachapalle Reddi Sudhir; P Pavani Murthy; Sudhir Ranganath; Uday B Kompella; Prema Padmanabhan
Journal:  PLoS One       Date:  2018-06-19       Impact factor: 3.240

10.  Ability of Mn(2+) to Permeate the Eye and Availability of Manganese-enhanced Magnetic Resonance Imaging for Visual Pathway Imaging via Topical Administration.

Authors:  Yao Chen; Chun-Yan Shi; Ying Li; Yun-Tao Hu; Hong-Bin Han; Xiao-Dong Sun; Satyajeet S Salvi; Zhi-Zhong Ma
Journal:  Chin Med J (Engl)       Date:  2016-08-05       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.